News

Deep dive on pay packages; Lilly strikes $3.2B buyout; Pfizer’s R&D head to depart; and more

Welcome back to Endpoints Weekly, your review of the week’s top biopharma headlines. Want this in your inbox every Saturday morning? Current Endpoints readers can visit their reader profile to add Endpoints Weekly. New to Endpoints? Sign up here. With big… … […]

News

Metagenomi science chief departs, just a few months after IPO

The chief scientific officer at gene editing company Metagenomi is out, the company confirmed to Endpoints News. “As of yesterday, I have parted ways with Metagenomi by mutual agreement,” CSO Luis Borges posted to LinkedIn last week. He had joined the company last year after serving in… … […]

No Picture
News

Thermo Fisher Scientific Declares Quarterly Dividend

WALTHAM, Mass.–(BUSINESS WIRE)–Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its Board of Directors authorized a quarterly cash dividend of $0.39 per common share, payable on October 15, 2024, to shareholders of record as of September 13, 2024. About Thermo Fisher Scientific Thermo… … […]

No Picture
News

Tiba wins BARDA contract to develop RNA bird flu vaccine

The Biomedical Advanced Research and Development Authority (BARDA) has awarded a $749,999 contract to Cambridge, Massachusetts-based Tiba Biotech to develop a new RNA-based vaccine against bird flu.  In a July 11 press release, Tiba announced that BARDA had selected it for an EZ-BAA contract under the Flexible… … […]